436 Studies Now Enrolling
Developing Tailored Delivery and Adherence Interventions for use of Long-Acting Biomedical HIV Prevention Strategies by Transgender Women
Using Saline (Sterile Salted Sater) Injections to Learn About New Ways to Inject PrEP
| Sponsor: | NIMH |
| Enrolling: | Female Patients Only |
| Study Length: | 6 Months |
| Clinic Visits: | 4 |
| IRB Number: | 7703 |
| U.S. Govt. ID: | NCT03856580 |
| Contact: | Walter Bockting: 646-774-6937 / wb2273@cumc.columbia.edu |
Additional Study Information:
We want to make PrEP better for transgender women! Your input will help us to understand how to support transgender women who use a potential future HIV prevention product: injectable PrEP. In this study, we will show you short videos on potential different ways to inject PrEP. Then, we will randomly assign you to our "intervention" or "control" groups. If you are assigned to our "intervention group" you will get to pick the injection strategy you want to use! It is important to know that this is a placebo study, and nobody will inject "real" PrEP. Instead, we will use a sterile saline solution. Your first visit will take about 1 hour of your time, and all participants will be involved for 6 months. Depending on your study group, your length of visit time for subsequent visits could be as short as 10 minutes. This study offers compensation - you can make up to $250.
This study is closed
Do You Qualify?
| Were you assigned male at birth? | Yes | No |
| Do you currently identify as a woman, transgender woman, woman of transgender experience, or another gender? | Yes | No |
| During the last 3 months did you have sex with another person? Sex can be anal, vaginal, or oral | Yes | No |
| Do you currently have any silicone implants in your hip, buttock, or thigh area? | Yes | No |
| Have you ever tested HIV-positive? | Yes | No |